Adenovirus E1A orchestrates the urokinase-plasminogen activator system and upregulates PAI-2 expression, supporting a tumor suppressor effect

International Journal of Oncology

Volumn 28, Issue 1, 2006, Pages 143-148

  Fernandez Soria V ^a   Lleonart, M E ^a   Diaz Fuertes, M ^a   Villuendas, R ^b   Sanchez Prieto R ^c   Fabra, A ^d   Ramon Y Cajal S ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

^c UCLM   (Spain)

^d Institut de Recerca Oncologica   (Spain)

Author keywords

Adenovirus E1A; PAI 2 expression; Plasminogen system; Tumor suppressor; Upregulates

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; SERPINE1 PROTEIN, HUMAN; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CANCER INVASION; CARCINOMA; CELL CULTURE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METASTASIS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADENOVIRIDAE; ADENOVIRUS EARLY PROTEINS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33644800666     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.1.143     Document Type: Article

References (36)

1. Liu F and Green MR: Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains. Nature 368: 520-525, 1994.
2. Song CZ, Loewenstein PM, Toth K, Tang Q, Nishikawa A and Green M: The adenovirus E1A repression domain disrupts the interaction between the TATA binding protein and the TATA box in a manner reversible by TFIIB. Mol Cell Biol 17: 2186-2193, 1997.
3. MacLellan WR, Xiao G, Abdellatif M and Schneider MD: A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol 20: 8903-8915, 2000.
4. Shuen M, Avvakumov N, Torchia J and Mymryk JS: The E1A proteins of all six human adenovirus subgroups target the p300/CBP acetyltransferases and the SAGA transcriptional regulatory complex. Virology 316: 75-83, 2003.
5. Mymryk JS: Tumour suppressive properties of the adenovirus 5 E1A oncogene. Oncogene 13: 1581-1589, 1996.
6. Lavia P, Mileo AM, Giordano A and Paggi MG: Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene 22: 6508-6516, 2003. (Pubitemid 37372330)
7. Sánchez-Prieto R, Quintanilla M, Cano A, LLeonart ME, Martín P, Anaya A and Ramón y Cajal S: In vivo tumor suppressor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene. Oncogene 13: 1083-1092, 1996.
8. Viniegra JG, Losa JH, Sanchez-Arevalo VJ, Cobo CP, Soria VM, Ramon y Cajal S and Sanchez-Prieto R: Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin. Oncogene 21: 7131-7136, 2002.
9. Sánchez-Prieto R, Quintanilla M, Martín P, LLeonart ME, Cano A, Dotto GP and Ramón y Cajal S: In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene. Cancer Gene Ther 5: 215-224, 1998.
10. Fabra A, Parada C, Vinyals A, Martin Duque P, Fernandez V, Sanchez-Prieto R and Ramón y Cajal S: Intravascular injections of a conditional replicative adenovirus (adl118) prevent metastatic disease in human breast carcinoma xenografts. Gene Ther 8: 1627-1634, 2001.
11. Bernhard EJ, Hagner B, Wong C, Lubenski I and Muschel RJ: The effect of E1A transfection on MMP-9 expression and metastatic potential. Int J Cancer 60: 718-724, 1995.
12. Somasundaram K, Jayaraman G, Williams T, Moran E, Frisch S and Thimmapaya B: Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci USA 93: 3088-3093, 1996.
13. Santoro M, Battaglia C, Zhang L, Carlomagno F, Martelli ML, Salvatore D and Fusco A: Cloning of the rat tissue inhibitor of metalloproteinases type 2 (TIMP-2) gene: analysis of its expression in normal and transformed thyroid cells. Exp Cell Res 213: 398-403, 1994.
14. Sidenius N and Blasi F: The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy. Cancer Metastasis Rev 22: 205-222, 2003.
15. Choong PF and Nadesapillai AP: Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis. Clin Orthop 415 (suppl): S46-S58, 2003.
16. Tracey L, Villuendas R, Ortiz P, Dopazo A, Spiteri I, Lombardia L, Rodriguez-Peralto JL, Fernandez-Herrera J, Hernandez A, Fraga J, Dominguez O, Herrero J, Alonso MA, Dopazo J and Piris MA: Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol 161: 1825-1837, 2002.
17. Herrero J, Díaz-Uriarte R and Dopazo J: Gene expression data preprocessing. Bioinformatics 19: 655-656, 2003.
18. Kruithof EK, Baker MS, and Bunn CL: Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86: 4007-4024, 1995.
19. Mueller BM, Yu YB and Laug WE: Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice. Proc Natl Acad Sci USA 92: 205-209, 1995.
20. Dickinson JL, Bates EJ, Ferrante A and Antalis TM: Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 270: 27894-27904, 1995.
21. Dickinson JL, Norris BJ, Jensen PH and Antalis TM: The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis. Cell Death Differ 5: 163-171, 1998.
22. Varro A, Hemers E, Archer D, Pagliocca A, Haigh C, Ahmed S, Dimaline R and Dockray GJ: Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin. Gastroenterology 123: 271-280, 2002.
23. Maguire K, Shi XP, Horikoshi N, Rappaport J, Rosenberg M and Weinmann R: Interactions between adenovirus E1A and members of the AP-1 family of cellular transcription factors. Oncogene 6: 1417-1422, 1991.
24. Kitabayashi I, Chiu R, Gachelin G and Yokoyama K: E1A dependent up-regulation of c-jun/AP-1 activity. Nucleic Acids Res 19: 649-655, 1991.
25. Darnell GA, Antalis TM, Johnstone RW, Stringer BW, Ogbourne SM, Harrich D and Suhrbier A: Inhibition of retino-blastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif. Mol Cell Biol 23: 6520-6532, 2003.
26. Nakamura M, Konno H, Tanaka T, Maruo Y, Nishino N, Aoki K, Baba S, Sakaguchi S, Takada Y and Takada A: Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues. Thromb Res 65: 709-719, 1992.
27. Foekens JA, Buessecker F, Peters HA, Krainick U, van Putten WL, Look MP, Klijn JG and Kramer MD: Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer. Cancer Res 55: 1423-1427, 1995.
28. Yoshino H, Endo Y, Watanabe Y and Sasaki T: Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis. Br J Cancer 78: 833-839, 1998.
29. Praus M, Wauterickx K, Collen D and Gerard RD: Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther 6: 227-236, 1999.
30. Frisch SM and Mymryk JS: Adenovirus-5 E1A: paradox and paradigm. Nat Rev Mol Cell Biol 3: 441-452, 2002.
31. Bondesson M, Mannervik M, Akusjarvi G and Svensson C: An adenovirus E1A transcriptional repressor domain functions as an activator when tethered to a promoter. Nucleic Acids Res 22: 3053-3060, 1994.
32. Gallimore PH and Turnell AS: Adenovirus E1A: remodelling the host cell, a life or death experience. Oncogene 20: 7824-7835, 2001.
33. Giordano A, Lee JH, Scheppler JA, Herrmann C, Harlow E, Deuschle U, Beach D and Franza BR Jr: Cell cycle regulation of histone H1 kinase activity associated with the adenoviral protein E1A. Science 253: 1271-1275, 1991.
34. Shuen M, Avvakumov N, Walfish PG, Brandl CJ and Mymryk JS: The adenovirus E1A protein targets the SAGA but not the ADA transcriptional regulatory complex through multiple independent domains. J Biol Chem 277: 30844-30851, 2002.
35. Stevens JL, Cantin GT, Wang G, Shevchenko A, Shevchenko A and Berk AJ: Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit. Science 296: 755-758, 2002.
36. Cantin GT, Stevens JL and Berk AJ: Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc Natl Acad Sci USA 100: 12003-12008, 2003.